Goldman Sachs Downgrades Aetna To Neutral
Analysts at Goldman Sachs downgraded Aetna (NYSE: AET) from Buy to Neutral.
The target price for Aetna has been lowered from $94.00 to $88.00.
Aetna shares have surged 24.00% over the past 52 weeks, while the S&P 500 index has gained 13.56% in the same period.
Aetna's shares dropped 0.61% to $77.84 in pre-market trading.
Latest Ratings for AET
|Feb 2016||BMO Capital||Maintains||Outperform|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.